Effect of Spinal Magnetic Stimulation on Management of Functional Constipation in Adults
Launched by UNIVERSITY OF ALEXANDRIA · Jan 22, 2022
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Constipation varies in presentation and severity among patients and affects patients' quality of life of varied degrees depending on how it manifests and how severe it is. The prevalence of constipation in the general population is estimated to affect about 20% of the population
Spinal Magnetic Stimulation (SMS) is a non-invasive, painless neurophysiological treatment that uses extracorporeal magnetic stimulation to direct extracorporeal magnetic stimulation to the spinal nerves and deep muscles to aid bowl evacuation without the use of surgery. This noninvasive approach was created to hel...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults patients diagnosed by Rome IV criteria as having functional constipation
- Exclusion Criteria:
- • Patients younger than 18 years old.
- • Patients with irritable bowel syndrome.
- • Anal hemorrhoids or bleeding.
- • Any condition that may complicate bowel problems, such as Parkinson's disease, stroke, or traumatic brain injury.
About University Of Alexandria
The University of Alexandria, a leading academic institution in Egypt, is committed to advancing medical research and clinical innovation through rigorous scientific inquiry. With a strong emphasis on interdisciplinary collaboration, the university fosters a vibrant research environment that supports clinical trials aimed at improving patient outcomes and enhancing healthcare delivery. Leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the University of Alexandria is dedicated to contributing valuable insights to the global medical community while prioritizing ethical standards and patient safety in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
Nehad ElShatby, MD,PhD
Principal Investigator
Alexandria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials